Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 54: 1053-1059, 2008. First published April 17, 2008; 10.1373/clinchem.2007.097857
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
clinchem.2007.097857v1
54/6/1053    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Zanella-Cleon, I.
Right arrow Articles by Francina, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zanella-Cleon, I.
Right arrow Articles by Francina, A.
Related Collections
Right arrow Hematology
(Clinical Chemistry. 2008;54:1053-1059.)
© 2008 American Association for Clinical Chemistry, Inc.

Hematology

Detection of a Thalassemic {alpha}-Chain Variant (Hemoglobin Groene Hart) by Reversed-Phase Liquid Chromatography

Isabelle Zanella-Cleon1, Michel Becchi1, Philippe Lacan2, Piero C. Giordano3, Henri Wajcman4,5 and Alain Francina2,a

1 Institut de Biologie et de Biochimie des Protéines, IFR128, Université Claude Bernard-Lyon I, Lyon, France; 2 Unité de Pathologie Moléculaire, Fédération de Biochimie et de Biologie Spécialisée, Hôpital Edouard Herriot, Hospices Civils, Université Claude Bernard-Lyon I, Lyon, France;3 Hemoglobinopathies Laboratory, Department of Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands; 4 INSERM U 841, Créteil, France;5 Biochimie Génétique, Hôpital Henri Mondor, Créteil, France.

aAddress correspondence to this author at: Unité de Pathologie Moléculaire, Fédération de Biochimie et de Biologie Spécialisée, Hôpital Edouard Herriot, 69437 Lyon Cedex 03, France. Fax 33-0472110598; e-mail alain.francina{at}chu-lyon.fr

Background: Hemoglobin (Hb) Groene Hart [{alpha}119 (H2)Pro->Ser ({alpha}1)], also known as Hb Bernalda, is a nondeletional {alpha}-thalassemic Hb variant that is frequent in southern Italy and North Africa. This variant is not supposed to be produced in the erythrocytes of carriers. The {alpha}-thalassemic behavior of this variant has been explained as an impaired interaction between the {alpha}-globin chain and the {alpha}-Hb–stabilizing protein.

Methods: To separate globin chains, we developed a modified reversed-phase liquid chromatography (RPLC) procedure that uses acetonitrile–water solvents containing up to 3 mL/L trifluoroacetic acid. After RPLC, we characterized the isolated globin chains by electrospray ionization (ESI) mass spectrometry (MS) and analyzed their tryptic peptides with matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) MS and nano-LC–ESI–MS/MS.

Results: RPLC detected an abnormal peak with a retention time substantially greater than that of the wild-type {alpha}A-globin chain. We identified this variant as Hb Groene Hart and found it in the hemolysates of 11 unrelated patients (1 homozygote, 9 heterozygotes, and 1 heterozygote associated with the –{alpha}3.7 deletion). These patients possessed abnormal hematologic features suggesting an {alpha}-thalassemia phenotype. Molecular modeling suggested that the increase in hydrophobicity was due to opening of the GH interhelical segment following replacement of amino acid residue 119 with a nonhelix breaker residue.

Conclusions: This method allows the detection of Hb variants at low concentrations, and adjusting the composition of the organic solvents enables the method to identify Hb variants with large changes in hydrophobicity.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Association for Clinical Chemistry.